The Function of Nutrition Rich Vegan Drink on Inflammatory Bowel Disease
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this project, would be to develop a new formula, with high nutrition content on a vegan basis. The investigators expect to produce this novel vegan-based juice product, which does not exist on the marked today. The juice would consist of different selected varieties of vegetables and fruits. Beside the vegetables, the juice will also contain plant oils to increase the calorie level, as well as a protein sources containing amino acids with high anabolic effects. The products will be tested in an intervention study on patients with inflammatory bowel disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2019
CompletedStudy Start
First participant enrolled
March 3, 2020
CompletedFirst Posted
Study publicly available on registry
March 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFebruary 1, 2022
January 1, 2022
2.2 years
February 21, 2019
January 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Inflammatory factors
F-calprotectin
3 weeks
Study Arms (2)
Vegan drink
ACTIVE COMPARATORTreatment group
Control
PLACEBO COMPARATORPlacebo group
Interventions
Vegan based drink containing vegetables, fruits and plant oils. Dose: 500 mL a day
Eligibility Criteria
You may qualify if:
- Between 18 and 85 years old
- Diagnosed with or show signs of UC or Crohns disease
- Mild symptoms i.e intestinal symptoms
- Has had the same medicin the previous week before starting in the study
You may not qualify if:
- Food or vegetable allergi
- Cognitive diseases e.g alzheimers or dementia
- Has diabetes requiring insulin or GLP-1 analog treatment (NB: No does include T2D patients, taking tablets or other diabetes therapy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Per Bendix Jeppesenlead
- Future Food Innovationcollaborator
Study Sites (1)
Aarhus university
Aarhus N, 8200, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Per B Jeppesen, Prof
Department of clinical medicin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate. Prof, PhD.
Study Record Dates
First Submitted
February 21, 2019
First Posted
March 6, 2020
Study Start
March 3, 2020
Primary Completion
June 1, 2022
Study Completion
December 1, 2022
Last Updated
February 1, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share